Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

Fri, 16th Mar 2018 18:11

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants exercise.

The company received exercise notices from warrant holders to exercise warrants over an aggregate 260,000 shares of common stock, with an exercise price of 18.75 cents per share. The warrants were granted pursuant to the public offering announced on December 19, 2017.

Shares in the company closed at 49.45 pence, down 1.1%.


Shares in this article

Related News

Akers Biosciences appoints chief executive after settling legal battle
8 Oct 2018

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute wit...

Akers Biosciences profits hit over antigen difficulties
15 Aug 2018

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid as...

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs
3 Apr 2018

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.T...